Literature DB >> 8090923

Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography.

P Soyer1, D A Bluemke, R H Hruban, J V Sitzmann, E K Fishman.   

Abstract

PURPOSE: To determine the sensitivity and false-positive rate of helical computed tomography during arterial portography (CTAP) in the detection of hepatic metastases from colorectal cancer.
MATERIALS AND METHODS: Preoperative helical CTAP was performed to examine 23 patients (10 men and 13 women, aged 43-77 years [mean, 63 years]) who later underwent surgical tumor resection. Imaging findings were retrospectively reviewed by two radiologists and were correlated with intraoperative and histologic findings.
RESULTS: Helical CTAP demonstrated 33 of 35 metastases, with diameters of 4-95 mm, that were identified in resected specimens (sensitivity, 94%). The two metastases not demonstrated were 4 and 5 mm in diameter. Five false-positive lesions were found in four patients, yielding a false-positive rate of 17% by patient analysis and 13% by lesion analysis.
CONCLUSION: The sensitivity of helical CTAP in the preoperative detection of hepatic metastases is high, and its false-positive rate compares favorably with that of conventional CTAP, but future comparative studies are needed to determine which is the better modality.

Entities:  

Mesh:

Year:  1994        PMID: 8090923     DOI: 10.1148/radiology.193.1.8090923

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

Review 1.  [Modern imaging for liver metastases from colorectal tumors].

Authors:  J Gaa; H Wieder; M Schwaiger; E J Rummeny
Journal:  Chirurg       Date:  2005-06       Impact factor: 0.955

2.  MR-arterioportography: a new technical approach for detection of liver lesions.

Authors:  Janine Rennert; Ernst-Michael Jung; Andreas G Schreyer; Patrick Hoffstetter; Peter Heiss; Stefan Feuerbach; Niels Zorger
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

3.  Prospective, blinded comparison of helical CT and CT arterial portography in the assessment of hepatic metastasis from colorectal carcinoma.

Authors:  L Schwartz; L Brody; K Brown; A Covey; S Tuorto; M Mazumdar; E Riedel; W Jarnagin; G Getrajdman; Y Fong
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

4.  CT arterial portography in the staging of pancreatic malignancy.

Authors:  S Varshney; C N Hacking; C D Johnson
Journal:  Int J Pancreatol       Date:  2000-08

5.  Detection of liver metastases secondary to pancreatic cancer: utility of combined helical computed tomography during arterial portography with biphasic computed tomography-assisted hepatic arteriography.

Authors:  Yoshiaki Ikuta; Hiroshi Takamori; Osamu Ikeda; Hiroshi Tanaka; Yasuo Sakamoto; Daisuke Hashimoto; Nobuyuki Ozaki; Osamu Nakahara; Satoshi Furuhashi; Shinya Abe; Toru Beppu; Shinya Shimada; Yasuyuki Yamashita; Hideo Baba
Journal:  J Gastroenterol       Date:  2010-07-16       Impact factor: 7.527

6.  Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography.

Authors:  R Lencioni; F Donati; D Cioni; A Paolicchi; A Cicorelli; C Bartolozzi
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

Review 7.  Surgical therapy for colorectal metastases to the liver.

Authors:  Timothy M Pawlik; Michael A Choti
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

Review 8.  CT during arterial portography.

Authors:  P Soyer
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

9.  Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.

Authors:  Renate Hammerstingl; Alexander Huppertz; Josy Breuer; Thomas Balzer; Anthony Blakeborough; Rick Carter; Lluis Castells Fusté; Gertraud Heinz-Peer; Werner Judmaier; Michael Laniado; Riccardo M Manfredi; Didier G Mathieu; Dieter Müller; Koenraad Mortelè; Peter Reimer; Maximilian F Reiser; Philip J Robinson; Kohkan Shamsi; Michael Strotzer; Matthias Taupitz; Bernd Tombach; Gianluca Valeri; Bernhard E van Beers; Thomas J Vogl
Journal:  Eur Radiol       Date:  2007-12-06       Impact factor: 5.315

10.  SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic Adenocarcinomas.

Authors:  Yi-Jun Zhang; Jie-Wei Chen; Xiao-Sheng He; Hui-Zhong Zhang; Yi-Hong Ling; Jia-Huai Wen; Wei-Hao Deng; Peng Li; Jing-Ping Yun; Dan Xie; Mu-Yan Cai
Journal:  EBioMedicine       Date:  2018-01-09       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.